147 related articles for article (PubMed ID: 28245053)
1. Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
Chang JS; Kim KH; Yoon HI; Hyung WJ; Rha SY; Kim HS; Lee YC; Lim JS; Noh SH; Koom WS
Br J Surg; 2017 Jun; 104(7):877-884. PubMed ID: 28245053
[TBL] [Abstract][Full Text] [Related]
2. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes.
Aurello P; Catracchia V; Petrucciani N; D'Angelo F; Leonardo G; Picchetto A; Antolino L; Magistri P; Terrenato I; Lauro A; Ramacciato G
Am Surg; 2013 May; 79(5):483-91. PubMed ID: 23635583
[TBL] [Abstract][Full Text] [Related]
3. Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.
Chang JS; Kim KH; Keum KC; Noh SH; Lim JS; Kim HS; Rha SY; Lee YC; Hyung WJ; Koom WS
J Surg Oncol; 2016 Dec; 114(7):859-864. PubMed ID: 27511744
[TBL] [Abstract][Full Text] [Related]
4. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
[TBL] [Abstract][Full Text] [Related]
6. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.
Zhang CD; Shen MY; Zhang JK; Ning FL; Zhou BS; Dai DQ
Sci Rep; 2015 Nov; 5():17273. PubMed ID: 26602830
[TBL] [Abstract][Full Text] [Related]
8. Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer.
de Manzoni G; Verlato G; Bencivenga M; Marrelli D; Di Leo A; Giacopuzzi S; Cipollari C; Roviello F
Eur J Surg Oncol; 2015 Apr; 41(4):534-40. PubMed ID: 25707350
[TBL] [Abstract][Full Text] [Related]
9. Pathological features as predictors of recurrence after radical resection of gastric cancer.
Buzzoni R; Bajetta E; Di Bartolomeo M; Miceli R; Beretta E; Ferrario E; Mariani L
Br J Surg; 2006 Feb; 93(2):205-9. PubMed ID: 16363019
[TBL] [Abstract][Full Text] [Related]
10. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
[TBL] [Abstract][Full Text] [Related]
12. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.
Kung CH; Tsai JA; Lundell L; Johansson J; Nilsson M; Lindblad M
BJS Open; 2020 Jun; 4(3):424-431. PubMed ID: 32129948
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
14. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
15. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
16. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
17. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy.
Schwarz RE; Zagala-Nevarez K
Ann Surg Oncol; 2002 May; 9(4):394-400. PubMed ID: 11986192
[TBL] [Abstract][Full Text] [Related]
18. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
19. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer.
Díaz de Liaño A; Yarnoz C; Aguilar R; Artieda C; Ortiz H
Gastric Cancer; 2008; 11(2):96-102. PubMed ID: 18595016
[TBL] [Abstract][Full Text] [Related]
20. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
